Literature DB >> 17195703

Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program.

Ilana Belmaker1, Larissa Dukhan, Yochi Yosef, Alex Leventhal, Ron Dagan.   

Abstract

BACKGROUND: In 1999, Israel became the first country to begin universal toddler immunization against hepatitis A infection with a 2-dose schedule at 18 and 24 months. The effect of the Israeli program on outbreaks of Hepatitis A in day care and school settings was studied.
METHODS: The records of all hepatitis A illness outbreaks in day care and school settings reported to the Ministry of Health in Southern Israel during 1993 through 2005 were reviewed. The number of exposed contacts for whom postexposure prophylaxis was administered was retrieved from records of epidemiologic investigations. Rates of immunization coverage were extracted from records of Maternal and Child Health Clinics.
RESULTS: Three hundred nineteen cases of hepatitis A illness during the years 1993 through 2005 were associated with 113 outbreaks in day care and school settings of which 92% occurred before the institution of universal toddler immunization. Since 2000, no hepatitis A infection outbreaks have been reported in any day care and school settings in the region. An average of 732 children received immunoglobulin prophylaxis yearly because of exposure to an outbreak in an educational setting during the preimmunization period, 106 in 2000 and zero in the 5 years since 2001. The data showed marked herd immunity since school-aged children born before 1999 were not immunized, but elimination of outbreaks occurred equally in that age group. Immunization coverage was 86.4% for one dose of hepatitis A vaccine by age 3 years and 77.3% for 2 doses among the birth cohort of 2000.
CONCLUSIONS: Universal hepatitis A immunization of toddlers was associated with disappearance of outbreaks in educational settings. This included cohorts of nonimmunized children representing marked herd immunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17195703     DOI: 10.1097/01.inf.0000247105.45185.13

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Changes in the epidemiology of hepatitis A outbreaks 13 years after the introduction of a mass vaccination program.

Authors:  Ana Martínez; Sonia Broner; M Rosa Sala; Sandra Manzanares-Laya; Pere Godoy; Caritat Planas; Sofia Minguell; Nuria Torner; Mireia Jané; Angela Domínguez; The Working Group For The Study Of The Immune Status In Health Care; For The Study Of Hepatitis A In Catalonia
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

2.  Impact of self-financed rotavirus vaccination on acute gastroenteritis in young children in Turkey.

Authors:  Erdem Gönüllü; Ahmet Soysal; İsmail Yıldız; Metin Karaböcüoğlu
Journal:  Hum Vaccin Immunother       Date:  2020-07-23       Impact factor: 3.452

3.  Hepatitis A Vaccination Rates and Related Factors in a 2005 Population-based Study in Nonsan, Korea.

Authors:  Eun Young Kim; Baeg Ju Na; Moo Sik Lee; Keon Yeop Kim; Moran Ki
Journal:  Epidemiol Health       Date:  2009-10-12

4.  Factors associated to duration of hepatitis a outbreaks: implications for control.

Authors:  Nuria Torner; Sonia Broner; Ana Martinez; Cecilia Tortajada; Patricia Garcia de Olalla; Irene Barrabeig; MariaRosa Sala; Neus Camps; Sofia Minguell; Josep Alvarez; Gloria Ferrús; Roser Torra; Pere Godoy; Angela Dominguez
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

Review 5.  Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review.

Authors:  Anke L Stuurman; Cinzia Marano; Eveline M Bunge; Laurence De Moerlooze; Daniel Shouval
Journal:  Hum Vaccin Immunother       Date:  2016-10-27       Impact factor: 3.452

Review 6.  Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence.

Authors:  Christian Herzog; Koen Van Herck; Pierre Van Damme
Journal:  Hum Vaccin Immunother       Date:  2020-12-16       Impact factor: 3.452

7.  Methods to assess the impact of mass oral cholera vaccination campaigns under real field conditions.

Authors:  Jacqueline Deen; Mohammad Ali; David Sack
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.